Check-Cap Ltd

7CC

Company Profile

  • Business description

    Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

  • Contact

    29 Abba Hushi Avenue
    Check-Cap Building, P.O. Box 1271
    Isfiya3009000
    ISR

    T: +972 48303400

    E: [email protected]

    https://www.check-cap.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    85

Stocks News & Analysis

stocks

Investors punish this ASX player after acquisition

We think the floundering stock price is not reflective of underlying asset value.
stocks

Revenue growth on track for undervalued ASX healthcare stock

Near-term cost growth does not change our long-term view.
stocks

Sales shine but broader macro outlook darkens for this ASX share

US stores are struggling, but our investment thesis hinges on the Australian rollout.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,137.3015.500.17%
CAC 408,245.8018.07-0.22%
DAX 4023,806.99273.64-1.14%
Dow JONES (US)48,185.80275.880.58%
FTSE 10010,603.485.40-0.05%
HKSE25,925.74173.340.67%
NASDAQ22,822.42187.420.83%
Nikkei 22556,948.041,052.721.88%
NZX 50 Index13,163.94109.87-0.83%
S&P 5006,824.6641.850.62%
S&P/ASX 2008,945.2020.800.23%
SSE Composite Index3,991.1424.960.63%

Market Movers